The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions

Author:

Kim Dong-Wan1ORCID,Schram Alison M2,Hollebecque Antoine3,Nishino Kazumi4,Macarulla Teresa5,Rha Sun Young6,Duruisseaux Michaël789,Liu Stephen V10,Al Hallak Mohammed Najeeb11,Umemoto Kumiko12,Wesseler Claas13,Cleary James M1415,Springfeld Christoph16,Neuzillet Cindy17,Joe Andrew18,Jauhari Shekeab18,Ford Jim19,Goto Koichi20

Affiliation:

1. Department of Internal Medicine, Seoul National University College of Medicine & Seoul National University Hospital, Seoul, 03080, Republic of Korea

2. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA

3. Drug Development (DITEP), GI Oncology, Gustave Roussy Cancer Campus, Villejuif, 94805, France

4. Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, 540-0008, Japan

5. Gastrointestinal and Endocrine Tumor Unit, Vall d´Hebrón University Hospital, Vall d´Hebrón Institute of Oncology (VHIO), Barcelona, 08035, Spain

6. Department of Internal Medicine, Yonsei Cancer Center, Yonsei University Health System, Seoul, 03722, Republic of Korea

7. Department of Respiratory Medicine and Early Phase, Louis Pradel Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, 69500, France

8. Cancer Research Centre of Lyon, UMR INSERM 1052 CNRS 5286, Lyon, 69008, France

9. Claude Bernard University Lyon 1, University of Lyon, Villeurbanne, 69100, France

10. Thoracic Oncology and Developmental Therapeutics, Lombardi Comprehensive Cancer Center, Georgetown University, WA 20007, USA

11. Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA

12. Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, 216-8511, Japan

13. Department of Pulmonology, Asklepios Tumorzentrum Hamburg, Klinikum Harburg, Hamburg, 21075, Germany

14. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA

15. Harvard Medical School, Boston, MA 02215, USA

16. Department of Medical Oncology, Heidelberg University Hospital, Department of Medical Oncology, Heidelberg, 69120, Germany

17. GI Oncology, Medical Oncology Department, Curie Institute, Versailles-Saint Quentin University, Saint-Cloud, 92064, France

18. Clinical Development, Merus NV, Utrecht, 3584, The Netherlands

19. Clinical Trials, Merus NV, Utrecht, 3584, The Netherlands

20. Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, 277-8577, Japan

Funder

Merus NV

Publisher

Informa UK Limited

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3